GENE ONLINE|News &
Opinion
Blog

Asthma
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Can Your Smartwatch Help You Manage Asthma Better?
2020-09-19
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Scroll to Top